rethinkTHC Search
Menu
Study breakdown

87% of Medical Cannabis Patients Report Using It as a Substitute for Prescription Drugs, Alcohol, or Illicit Substances

Cross SectionalModerate evidence
The takeaway

A survey of 473 Canadian medical cannabis patients found that 87% used cannabis as a substitute for at least one other substance, with 80% substituting for prescription drugs, 52% for alcohol, and 33% for illicit substances.

Read this if you are interested in whether medical cannabis can replace other medications or substances.

80% of medical cannabis patients substituted cannabis for prescription drugs

What the researchers found

This large survey of Canadian medical cannabis patients revealed remarkably high rates of substance substitution. Among 473 respondents, 87% reported substituting cannabis for at least one other substance category.

The most common substitution was for prescription drugs (80.3%), followed by alcohol (51.7%) and illicit substances (32.6%). Patients under 40 were more likely to substitute cannabis for all three categories.

An important finding was that patients who substituted cannabis for prescription drugs were more likely to report difficulty affording enough cannabis, suggesting that cost barriers may limit the substitution effect. The authors argue this points to a harm reduction role for medical cannabis.

Why it matters

The finding that 80% of medical cannabis patients reduce prescription drug use has enormous implications for the opioid crisis, polypharmacy management, and healthcare costs. If cannabis can safely replace even a fraction of prescription medications, the public health impact could be substantial.

The numbers in context

473 medical cannabis patients surveyed. 87% substituted cannabis for at least one substance. 80.3% for prescription drugs. 51.7% for alcohol. 32.6% for illicit substances. Patients under 40 more likely to substitute across all categories. Cost barriers limited substitution.

How the study worked

Cross-sectional survey (414 questions) of 473 Canadian medical cannabis patients, available online and in hard copy in 2011-2012. Assessed demographics, medical conditions, use patterns, substitution behavior, and access barriers.

What this study cannot tell us

Self-selected sample of patients already committed to medical cannabis. No objective verification of reduced prescription drug use. Patients who substituted successfully may be more likely to respond. Cannot determine whether substitution led to better or worse health outcomes. Cross-sectional design.

How to read the evidence

Large survey with detailed questioning, but self-selected sample and self-reported substitution without objective verification.

When this study was published

Published in 2016 using 2011-2012 data. Canadian cannabis access has expanded dramatically since full legalization in 2018.

The bigger picture

This study adds to growing evidence that medical cannabis may function as a harm reduction tool. The prescription drug substitution finding is particularly relevant given the opioid epidemic, suggesting cannabis may provide an alternative for some patients currently relying on opioids and other potentially harmful medications.

Questions still open

  • Does substituting cannabis for prescription drugs lead to better health outcomes? Would insurance coverage for medical cannabis increase substitution rates? Which specific prescription drugs are most commonly replaced?

Common questions

Do medical cannabis patients use fewer other drugs?
In this survey, 80% of medical cannabis patients reported substituting cannabis for prescription drugs, suggesting many patients use cannabis to reduce reliance on other medications.
Does cannabis help people drink less alcohol?
Over half (52%) of medical cannabis patients in this study reported substituting cannabis for alcohol, though whether this leads to better health outcomes requires further research.

Read the original research

Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors.

Drug and alcohol review, 35(3), 326-33

Citation

Lucas, Philippe; Walsh, Zach; Crosby, Kim; Callaway, Robert; Belle-Isle, Lynne; Kay, Robert; Capler, Rielle; Holtzman, Susan. (2016). Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors.. Drug and alcohol review, 35(3), 326-33. https://doi.org/10.1111/dar.12323

Explore the wider topic